Search results
Pfizer (NYSE:PFE) Stock Price Down 0.9%
ETF DAILY NEWS· 21 hours agoPfizer Inc. (NYSE:PFE – Get Free Report) was down 0.9% during trading on Thursday . The company traded as low as $27.20 and last traded at $27.41. Approximately 11,513,196 ...
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 6 days agoPfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might...
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
Motley Fool via Yahoo Finance· 8 hours agoThe S&P 500 is up an incredible 25% over the past 12 months, but not every stock in the benchmark...
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 3 days agoPfizer (PFE) closed the latest trading day at $27.66, indicating a -1.32% change from the previous...
Voisard Asset Management Group Inc. Takes $86,000 Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 20 hours agoVoisard Asset Management Group Inc. bought a new stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) during the 4th quarter, according to the company in its most recent ...
Is this the Time to Initiate a Pfizer (PFE) Position?
Insider Monkey via Yahoo Finance· 5 days agoDiamond Hill Capital, an investment management company, released its “Select Strategy” first-quarter...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 2 days agoIn the past six months, Lilly has risen the most (54.5%), while J&J has dropped the most (6.2%)....
Bridgeway Capital Management LLC Boosts Stock Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 3 days ago(NYSE:PFE – Free Report) by 26.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 466,252 shares ...
Is It Too Late to Buy Pfizer Stock?
Motley Fool via Yahoo Finance· 2 days agoAre Pfizer's (NYSE: PFE) best days behind it? If the stock's critics are to be believed, the answer is an emphatic "yes, obviously," with issues like its...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 4 days agoBut Pfizer stock hit its lowest point since January 2013 in April. Shares have risen about 10% since...